“Chilling effect” of Mayo and Myriad affecting patent applications
Legal specialists at the BIO conference in San Diego discussed two recent Supreme Court decisions and the subsequently issued USPTO guidance, expressing concerns about the determination of patent eligibility and what it means for future innovation. Marion Webb reports
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
